$1,199 – $1,590

11th International Conference on Tissue Engineering & Regenerative Medicin...

Event Information

Share this event

Date and Time

Location

Location

Metropolitan City of Rome

TBA

Metropolitan

Italy

View Map

Refund Policy

Refund Policy

No Refunds

Event description

Description

11th International Conference on Tissue Engineering & Regenerative Medicine


About the Conference

Conference Series llc LTD invites all participants to attend “11th International Conference on Tissue Engineering & Regenerative Medicine” which is going to be held during October 18-20, 2018 at Rome, Italy mainly focuses on two key topics viz. Tissue Engineering and Regenerative Medicine with basic theme “Redefining Health Care through Regenerative Medicine”.

Regenerative Medicine -2018 provides an ideal environment to discuss on recent strategies in tissue engineering and regenerative medicine for disease remediation and tissue repair.

11th International Conference on Tissue Engineering & Regenerative Medicine mainly focuses on Stem Cell Research and Tissue Engineering. Stem cell Research includes stem cell treatment for various disease and conditions include Diabetes, Rheumatoid arthritis, Parkinson's disease, Alzheimer's disease, Osteoarthritis, Stroke and traumatic brain injury repair, Learning disability due to congenital disorder, Spinal cord injury repair, Heart infarction, Anti-cancer treatments, Baldness reversal, Replace missing teeth, Repair hearing, Restore vision and repair damage to the cornea, Amyotrophic lateral sclerosis, Crohn's disease, Wound healing, Male infertility due to absence of spermatogonial stem cells etc., Tissue Engineering includes Bone tissue engineering, soft tissues, tissue imaging, tissue implant, cartilage and skin defects are a special focus along with applying basic science and engineering principles from diverse areas towards solving clinically relevant biomedical problems.

Conference Series llc LTD is a World’s leading Event Organizer that organizes 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Major Sessions:

Scaffolds
Cord Blood & Regenerative Medicine
Bone and Cartilage Tissue Engineering
Stem Cells-Tools to Battle Cancer
Novel Approaches in Guided Tissue Regeneration
Clinical Medicine
Clinical Trials with Stem Cells
Biomaterials and Bioengineering
Tissue Biomarkers
Regeneration and Therapeutics
Rejuvenation
Immunotherapy
Stem Cell Treatment for Diabetes
Applications of Tissue Engineering and Regenerative Medicine
Bioreactors in Tissue Engineering
Biochips and Tissue Chips
Cancer Stem Cells
Tissue Regeneration
Advances in Stem Cell
Materials and Designs for Tissue Engineering
Tissue Engineering and 3D Printing
Whole Organ Engineering and Approaches
Stem Cell Engineering (SCE)


Sessions/Tracks

Scaffolds

Scaffolds are one of the three most important elements constituting the basic concept of regenerative medicine, and are included in the core technology of regenerative medicine. Every day thousands of surgical procedures are performed to replace or repair tissue that has been damaged through disease or trauma. The developing field of tissue engineering (TE) aims to regenerate damaged tissues by combining cells from the body with highly porous scaffold biomaterials, which act as templates for tissue regeneration, to guide the growth of new tissue. Scaffolds has a prominent role in tissue regeneration the designs, fabrication, 3D models, surface ligands and molecular architecture, nanoparticle-cell interactions and porous of the scaffolds are been used in the field in attempts to regenerate different tissues and organs in the body. The world stem cell market was approximately 2.715 billion dollars in 2010, and with a growth rate of 16.8% annually, a market of 6.877 billion dollars will be formed in 2016. From 2017, the expected annual growth rate is 10.6%, which would expand the market to 11.38 billion dollars by 2021.

Tissue Regeneration

In the field of biology, regeneration is the progression of renewal, regeneration, and growth that makes it possible for genomes, cells, organ regeneration to natural changes or events that cause damage or disturbance. This study is carried out as craniofacial tissue engineering, in-situ tissue regeneration, adipose-derived stem cells for regenerative medicine which is also a breakthrough in cell culture technology. The study is not stopped with the regeneration of tissue where it is further carried out in relation with cell signalling, morphogenetic proteins. Most of the neurological disorders occurred accidental having a scope of recovery by replacement or repair of intervertebral discs repair, spinal fusion, and many more advancements. The global market for tissue engineering and regeneration products such as scaffolds, tissue implants, biomimetic materials reached $55.9 billion in 2010 and it is expected to reach $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%. It grows to $135 billion by 2024.

Advances in Stem Cell

Since the beginning of there has been a effective research in the field of stem cell biology, recent advances in the field of stem cell research mainly focused in the translation of scientific insights into new therapies. It represents a new strategy for organ and tissue repair in several pathologies. Additional treatment strategies are urgently needed due to donor organ shortage that costs many lives every year and results in lifelong immunosuppression. Stem cells are characterized by the ability to renew themselves and differentiating into a various range of specialized cell types. Stem cells have potential to treat various diseases, genetic bone marrow disorders and the treatment of malignant. Being all other stem cell applications highly experimental, Moreover, there is a growing body of evidence showing that administration of stem cells leads to the successful regeneration of tissues or organ.

Materials and Designs for Tissue Engineering

Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centered on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the bone regeneration with modern techniques like recombinant signalling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion and ossification are new generated techniques for tissue-engineering applications. The worldwide market for bone and cartilage repairs strategies is estimated about $300 million. During the last 10/15 years, the scientific community witnessed and reported the appearance of several sources of stem cells with both osteo and chondrogenic potential.

Tissue Engineering and 3D Printing

Aims to fabricate of multifunctional scaffolds that meet the mechanical, structural, and nutritional requirements based on optimized models. Computer-aided three-dimensional (3D) printing technology is driving major innovations in many areas, such as engineering, manufacturing, art, education and medicine. It is being applied to regenerative medicine to address the need for tissues and organs suitable for transplantation. Recently, it has shown a great promise in tissue fabrication with structural control from micro- to macro-scale by using a layer-by-layer approach. It involves additional complexities, such as choice of materials, cell types, growth and differentiation factors, and technical challenges related to the sensitivities of living cells and the construction of tissues. It has been already used for the generation and transplantation of several tissues, including multi-layered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilaginous structures. Other applications involve developing the high-throughput 3D-bioprinted tissue models for analysis, drug discovery, and pharmacological medicine. This track will cover several approaches that have advanced the field of 3D technology through novel fabrication methods of tissue engineering constructs.

Whole Organ Engineering and Approaches

Guided tissue regeneration is defined as procedures attempting to regenerate lost periodontal structures through differential tissue responses. Guided bone regeneration typically refers to ridge augmentation or bone regenerative procedures it typically refers to regeneration of periodontal therapy. The recent advancements and innovations in biomedical and regenerative tissue engineering techniques include the novel approach of guided tissue regeneration.

Stem Cell Engineering (SCE)

Stem cell engineering (SCE) was to gather information on the worldwide status and trends of research and development in field SCE, that is, the engineers and engineering approaches in the stem cell field, both in basic research and translation of research into clinical applications and commercial products. The study of Stem Cells Engineering is facilitated and managed by the World Technology Evaluation Center (WTEC). This will provide a support for the generation of future economic growth and new markets. The process involved site visits in both Europe and Asia, and it also included several different workshops.

Cord Blood Stem Cells and Regenerative Medicine

Recently, cord blood stems cells are developed in the treatment of different diseases, including a broad range of cancers, blood disorders, and genetic diseases. In a cord blood transplant, stem cells are infused in to a patient’s bloodstream for healing and repairing damaged cells and tissue. In a successful transplant, new healthy immune system has been created. The natural power and purity of newborn's cord blood are responsible for healthy development during gestation. Cord blood applications have developed beyond transplant medicine into the areas of regenerative medicine including brain injuries, autism, Cardiac Problems, and Autoimmune Deficiencies. The latest research in routine transplantation of cord blood are reviewed followed by the critical role of cord blood stem cells in regenerative medicine research and novel approaches using cord blood as a source of whole blood for transfusion.

Bone and Cartilage Tissue Engineering

This interdisciplinary engineering has attracted much attention as a new therapeutic means that may overcome the drawbacks involved in the current artificial organs and organ transplantation that have been also aiming at replacing lost or severely damaged tissues or organs. Tissue engineering and regenerative medicine is an exciting research area that aims at regenerative alternatives to harvested tissues for organ transplantation with soft tissues. Although significant progress has been made in the tissue engineering field, many challenges remain and further development in this area will require on-going interactions and collaborations among the scientists from multiple disciplines, and in partnership with the regulatory and the funding agencies. As a result of the medical and market potential, there is significant academic and corporate interest in this technology.

Cancer Stem Cells

Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumor-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.


Please contact the event manager Marilyn (marilyn.b.turner@nyeventslist.com ) below for:

- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorships

NO REFUNDS ALLOWED ON REGISTRATIONS
Service fees included in this listing.
-----------------------------------------------------------------
This event is brought to you by:
Conference Series - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

MYL180426CEV


Share with friends

Date and Time

Location

Metropolitan City of Rome

TBA

Metropolitan

Italy

View Map

Refund Policy

No Refunds

Save This Event

Event Saved